Monthly Meeting
Local Seminars
The Nucleus
Contact Us
 
 
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Medicinal Chemistry Group
Our Mission
The mission of the medicinal chemistry group is to advance knowledge and understanding of drug discovery research by organizing world class quality symposia.
Our meetings provide our attendees with access to top quality science presenters and offer unique networking connectivity with thought leaders in the scientific community.
Our members work at the forefront of the life science sector and are constantly striving to bring new medicines and therapies forward to the clinic to meet unmet need.

Volunteer Opportunities
The Medicinal chemistry group will be interested in volunteers to assist with annual symposium specifically for contacting potential vendors and fund-raising efforts. Please contact the med chem chair, Raj Rajur at rrajur@creagenbio.com, if interested.

Who are we?
     
   
  Dr. Raj (SB) Rajur, Chair
  rrajur@creagenbio.com
   
 
   
  Mark Ashwell
  Nimbus Therapeutics
mashwellmail@gmail.com
   
   
  Daniel Elbaum
  Retrophin
ddelbaum@msn.com
   
 
   
  Andrew Scholte
  Sanofi
Andrew.Scholte@genzyme.com
   
   
  Jeremy Green
  Vertex
jeremy_green@vrtx.com
   
 
   
  Blaise Lippa
  Morphic Therapeutic
Blaise.Lippa@morphictx.com
   
   
  Adrian Hobson
  Abbvie
   
 
   
  Alan Rigby
  Warp Drive Bio
   

Upcoming Symposium
Supporting Organizations
ACS, NESACS, RSC (US) and IUPAC
 
The Seventh Annual
Advances in Chemical Sciences Symposium
Location: Royal Sonesta Hotel
Cambridge, MA
Date: May 4th, 2018
A day-long symposium focusing on: Medicinal Chemistry, Organic Synthesis, and Methodology
Eminent scientists from industry and academia will deliver plenary lectures.

Speakers:
Professor Richard R. Schrock (MIT): “TBA”
Professor Dale L. Boger (Scripps Research Institute): “Redesign of Vancomycin for Resistant Bacteria”
Professor Laura Kiessling (MIT): “TBA”
Dr. Sue Ashwell (Forma Therapeutics): “Discovery and Optimization of a Novel Series of Inhibitors of mt-IDH1”
Dr. Michael Hoemann (Abbvie): “Discovery and Optimization of Spleen Tyrosine Kinase Inhibitors for Immunological Diseases”
Dr. Frank Salituro (Sage Therapeutics): “Discovery and Clinical Development of SAGE-217: A Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (GABA)A Receptor”

Plus:
Vendor Exhibition Hall and Networking Reception

Symposium registration fee: $ 50.00
Students: $25
On-line registration and payment: http://www.fourwav.es/acss2018
Alternatively send your full contact information and a check for $50 made payable to NESACS care of Dr. Ashish Saha, Treasurer, 67 Bow Street, Arlington, MA 02474
For additional details, please contact any of the Organizing Committee:

Raj Rajur (rrajur@creagenbio.com)
Mark Ashwell (mashwellmail@gmail.com)
Dan Elbaum (ddelbaum@msn.com)
Jeremy Green (jeremy_green@vrtx.com)
Andrew Scholte (Andrew.Scholte@genzyme.com)
Adrian Hobson (adrian.hobson@abbvie.com)
Brian Aquila (Brian.Aquila@alkermes.com)

Directions to Royal Sonesta Hotel:
Use the following address for your GPS: 40 Edwin H Land Blvd, Cambridge, MA 02142: Ph:(617) 806-4200
For more information including Agenda ...